SCHEMBL24658874

SCHEMBL24658874

Cc1cc(Cl)c(NC2=NCCN2)c(Cl)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 7/20 0.71
ADRA2B P18089 7/20 0.71
ADRA2C P18825 7/20 0.71
HTR1D P28221 5/20 0.71
HTR1B P28222 4/20 0.71
ADRA1D P25100 3/20 0.71
ADRA1A P35348 3/20 0.71
ADRA1B P35368 3/20 0.71
CYP2D6 P10635 3/20 0.71
NISCH Q9Y2I1 2/20 0.71
TSHR P16473 2/20 0.71
NFKB1 P19838 2/20 0.71
CYP1A2 P05177 1/20 0.71
HSD17B10 Q99714 1/20 0.71
LMNA P02545 4/20 0.69
BLM P54132 3/20 0.69
HIF1A Q16665 2/20 0.66
MEN1 O00255 1/20 0.66
SLC22A1 O15245 1/20 0.66
SLC22A3 O75751 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11761437 0.87 ADRA2C (0.71) ADRA2AADRA2BADRA2CHTR1DHTR1B
SCHEMBL11180812 0.86 ADRA2A (0.76) ADRA2AADRA2BADRA2CHTR1DHTR1B
Pi-Clonidine SCHEMBL563884 0.83 ADRA2A (1.00) ADRA2AADRA2BADRA2CHTR1DHTR1B
SCHEMBL10414088 0.83 ADRA2A (0.71) ADRA2AADRA2BADRA2CHTR1DHTR1B
Apraclonidine SCHEMBL34128 0.83 ADRA2A (1.00) ADRA2AADRA2BADRA2CHTR1DHTR1B
SCHEMBL11187565 0.83 HTR1D (0.76) ADRA2AADRA2BADRA2CHTR1DHTR1B
Apraclonidine SCHEMBL1002875 0.82 BLM (1.00) ADRA2AADRA2BADRA2CHTR1DHTR1B
Pi-Clonidine SCHEMBL5274141 0.82 LMNA (1.00) ADRA2AADRA2BADRA2CHTR1DHTR1B
Bromide SCHEMBL11608848 0.82 ADRA2A (0.69) ADRA2AADRA2BADRA2CHTR1DHTR1B
Apraclonidine SCHEMBL1649431 0.82 ADRA2A (0.97) ADRA2AADRA2BADRA2CHTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022221071-A1 ALPHA2 ADRENERGIC AGONIST CODRUGS CONJUGATED WITH MUSCARINIC AGONIST DRUGS ADS THERAPEUTICS LLC (US) 2022-10-20 WO disclosed